BridgeBio Pharma, Inc. (BBIO)
70.91
-0.12
(-0.17%)
USD |
NASDAQ |
Mar 17, 16:00
70.91
0.00 (0.00%)
After-Hours: 18:54
BridgeBio Pharma Shareholders Equity (Quarterly) : -2.087B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 738.98M |
| Pfizer Inc. | 86.48B |
| Mirum Pharmaceuticals, Inc. | 314.69M |
| Supernus Pharmaceuticals, Inc. | 1.062B |
| Cogent Biosciences, Inc. | 636.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 936.02M |
| Total Liabilities (Quarterly) | 3.013B |
| Debt to Equity Ratio | -1.308 |
| Current Ratio | 2.770 |
| Net Debt Paydown Yield | -1.34% |